the marked decrease in shbg and cholesterol levels during oral testosterone undecanoate , when compared with parenteral treatments , occurred despite lesser androgenic effects ( suppression of gonadotrophin levels and reported sexual function ) , which suggests that the liver is exposed to excessive androgenic load via the portal vein during oral treatment with testosterone esters .
C0036883
shbg
C0023884
liver